Austin Holt focuses on the representation of private and public companies with respect to executive compensation and employee benefits matters.

Download full bio 


  • Sweetgreen – $418.6 Million IPO 

  • PatientPop to Combine With Kareo to Form Tebra 

  • Vividion Therapeutics Agrees to Sell to Bayer for up to $2 Billion 

  • Lyell Immunopharma – $425 Million IPO 

  • Cooley Guides LegalZoom on IPO, Concurrent Private Placement 

  • View all

Practices & Industries


  • Georgetown University Law Center
    LLM, Taxation
    with distinction, 2009

  • Chapman University Dale E. Fowler School of Law
    JD, cum laude, 2008

  • Chapman University
    MBA, 2008

  • University of California, Riverside
    BA, Philosophy

Admissions & Credentials